Barth syndrome mutations that cause tafazzin complex lability.
about
Cardiolipin signaling mechanisms: collapse of asymmetry and oxidationAcyl coenzyme A thioesterase Them5/Acot15 is involved in cardiolipin remodeling and fatty liver developmentBarth Syndrome: From Mitochondrial Dysfunctions Associated with Aberrant Production of Reactive Oxygen Species to Pluripotent Stem Cell StudiesThe Role of Cardiolipin in Cardiovascular HealthSuccessful management of Barth syndrome: a systematic review highlighting the importance of a flexible and multidisciplinary approachDeacylation on the matrix side of the mitochondrial inner membrane regulates cardiolipin remodeling.Phosphatidylserine decarboxylase 1 autocatalysis and function does not require a mitochondrial-specific factor.Mechanism for Remodeling of the Acyl Chain Composition of Cardiolipin Catalyzed by Saccharomyces cerevisiae TafazzinMitochondrial protein turnover: role of the precursor intermediate peptidase Oct1 in protein stabilizationMitochondrial protein quality control: the mechanisms guarding mitochondrial healthYME1L degradation reduces mitochondrial proteolytic capacity during oxidative stressLPS impairs oxygen utilization in epithelia by triggering degradation of the mitochondrial enzyme Alcat1Defining functional classes of Barth syndrome mutation in humansDisorders of phospholipid metabolism: an emerging class of mitochondrial disease due to defects in nuclear genesThe complexity of cardiolipin in health and diseaseStress-triggered activation of the metalloprotease Oma1 involves its C-terminal region and is important for mitochondrial stress protection in yeastYeast as a system for modeling mitochondrial disease mechanisms and discovering therapies.Tafazzins from Drosophila and mammalian cells assemble in large protein complexes with a short half-life.Seven functional classes of Barth syndrome mutationThe power of yeast to model diseases of the powerhouse of the cell.The Taz1p transacylase is imported and sorted into the outer mitochondrial membrane via a membrane anchor domain.Structural and functional analyses of Barth syndrome-causing mutations and alternative splicing in the tafazzin acyltransferase domain.Lipidomics Characterization of Biosynthetic and Remodeling Pathways of Cardiolipins in Genetically and Nutritionally Manipulated Yeast CellsOverexpression of mitochondrial oxodicarboxylate carrier (ODC1) preserves oxidative phosphorylation in a yeast model of Barth syndrome.The Assembly Factor Pet117 Couples Heme a Synthase Activity to Cytochrome Oxidase Assembly.Stendomycin selectively inhibits TIM23-dependent mitochondrial protein import.Loss of function of SLC25A46 causes lethal congenital pontocerebellar hypoplasia.Multitiered and Cooperative Surveillance of Mitochondrial Phosphatidylserine Decarboxylase 1.Metalloproteases of the Inner Mitochondrial Membrane.Cardiomyopathy-associated mutation in the ADP/ATP carrier reveals translation-dependent regulation of cytochrome c oxidase activity.Tafazzin knockdown interrupts cell cycle progression in cultured neonatal ventricular fibroblasts.
P2860
Q23923191-4978965A-36B1-4954-95F5-2D76CBC8B72FQ24322562-67106C61-5955-41A8-A8A9-BA66C2316E26Q26772690-B2CBCE9F-E9C7-4032-BFAC-444846B45E36Q26798052-0ACDF46D-A573-4A63-B69E-DDBC90ED5664Q26801275-295E58AB-C9FA-46DF-88CE-F481D3EE55BEQ27932861-55EC4177-33AF-494F-8E70-A8038C8DE4CFQ27936560-1667C184-AE02-4672-BDFF-68574E45D2E6Q27939541-1BF88010-79F5-460A-90D8-EBC1A39A55E8Q27939949-8BBC4499-D9CE-44D7-95FB-0217CFAFEA09Q28083423-DBFAD544-4246-47B0-BA7D-2A80C2A22F95Q28252350-CF866F38-4EBB-49C3-9D66-22A95A9937F1Q28385337-FA26A87B-2D05-45E6-807D-D9117F51AA77Q28386747-038C58FB-6619-4440-B138-FB1F2DF9A913Q28387241-A91A95B3-8503-48EA-9C2B-9A57EA80554AQ28395624-8B613097-A043-4275-8144-64B2A99F2DFBQ33676633-387F0E64-7C87-4585-8507-1D8C374F47C8Q35687142-FB4DB73C-3B50-492F-9DD3-4DA810487461Q36409360-F05A3EE6-0AA2-4ABB-A864-A59F80764333Q36709665-FD20E166-FEE9-4BCB-81C4-20734CF5C434Q37418894-3539D3D8-6812-4285-89A0-4B160A88B680Q37469564-83C4DEA0-CB6E-4322-8AFE-C2C6D3510B7FQ40028882-38E2CF2B-F2BD-4C48-96D7-8D0C9510D56BQ41578012-558F4B6B-D7DD-4419-BEBB-F9F82FEED695Q42089787-6A286D40-19A3-43CB-A90A-98DAD0AEEA59Q42427959-11DF3D90-8AE6-4779-8A8B-0F16611A9E98Q46407655-231EB008-C71B-4581-8F91-1C5E3EC66F6FQ46815739-657B998C-D78B-4813-A73E-34B3E4334677Q47208255-94B0A277-7683-4932-9F66-F41A8592098DQ47956126-894092C7-293F-49CD-B465-669D5C8D923DQ52311110-12B05C8B-2A93-49EE-8F80-30DDC61496D4Q53091886-3BC19937-CA7B-4EDB-BD00-90673DF88DC1
P2860
Barth syndrome mutations that cause tafazzin complex lability.
description
2011 nî lūn-bûn
@nan
2011 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Barth syndrome mutations that cause tafazzin complex lability.
@ast
Barth syndrome mutations that cause tafazzin complex lability.
@en
type
label
Barth syndrome mutations that cause tafazzin complex lability.
@ast
Barth syndrome mutations that cause tafazzin complex lability.
@en
prefLabel
Barth syndrome mutations that cause tafazzin complex lability.
@ast
Barth syndrome mutations that cause tafazzin complex lability.
@en
P2093
P2860
P356
P1476
Barth syndrome mutations that cause tafazzin complex lability.
@en
P2093
Carla M Koehler
Kevin Whited
Santi Srijumnong
Steven M Claypool
Xianlin Han
P2860
P304
P356
10.1083/JCB.201008177
P407
P577
2011-02-01T00:00:00Z